Pulmatrix, Inc.
Develops inhaled therapies for respiratory and CNS disorders using its iSPERSE™ technology.
PULM | NDAQ
Overview
Corporate Details
- ISIN(s):
- US74584P3010
- LEI:
- Country:
- United States of America
- Address:
- 945 CONCORD STREET, 1701 FRAMINGHAM
- Website:
- https://www.pulmatrix.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Pulmatrix, Inc. is a clinical-stage biopharmaceutical company that develops and commercializes novel inhaled therapeutic products. The company leverages its proprietary iSPERSE™ technology platform to create innovative, pulmonary-delivered treatments for patients with serious diseases. Its product pipeline is focused on addressing serious respiratory and pulmonary diseases, as well as central nervous system (CNS) disorders. Pulmatrix aims to pioneer patient care and provide transformational medicines through its advanced inhalation technology.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Pulmatrix, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Pulmatrix, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Pulmatrix, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
